What You Should Know
- Fathom, a leader in autonomous medical coding, has announced a strategic investment from CVS Health Ventures.
- The funding follows a period where revenue cycle management (RCM) has become the top priority for health IT investment, according to a 2025 Bain & Company/KLAS report.
- Fathom’s platform achieves 90%+ automation rates across multiple specialties, providing an alternative to slow, department-by-department AI rollouts.
- The company was recognized as the #1 solution for Reducing the Cost of Care in the 2025 KLAS Emerging Solutions Top 20 Report.
- The investment will be used to serve growing demand from both providers and health plans nationwide.
As health systems face intensifying margin pressures, the manual task of medical coding has become a primary operational bottleneck. Fathom is addressing this “documentation tax” through its autonomous coding platform, which has now secured a strategic investment from CVS Health Ventures. The partnership signals a shift in the RCM market toward enterprise-grade AI that delivers immediate, measurable financial impact rather than theoretical efficiency gains.
By fusing deep learning and natural language processing, Fathom automates medical coding with high accuracy, reaching an inflection point where AI adoption in RCM is delivering demonstrable ROI. Andrew Lockhart, CEO of Fathom, noted that higher coding accuracy and consistency serve as a “true catalyst for financial performance at scale”.
System-Wide Implementation: Moving Beyond Point Solutions
A key differentiator for Fathom is its multi-specialty approach. Traditional AI implementations in healthcare often suffer from “technical debt” caused by sluggish, IT-intensive rollouts that tackle one department at a time. Fathom’s platform allows health systems to deploy autonomous coding across multiple departments in a single motion.
This system-wide model is designed to:
- Achieve 90%+ Successful Automation: Removing the need for manual intervention in the vast majority of coding tasks.
- Deliver Immediate Margin Impact: Providing a “light-lift” ROI that CFOs and revenue cycle leaders are increasingly demanding.
- Strengthen Payer-Provider Relationships: Using high accuracy to create a “trusted, consistent, and neutral representation” of care delivered, which can reduce friction during the claims process.
Validated Performance and Industry Recognition
Fathom’s market momentum is backed by significant third-party validation. In August 2025, the company received a 95.5/100 overall performance score in KLAS Research’s inaugural autonomous coding report. Furthermore, a 2024 KLAS Emerging Company Spotlight report indicated that 100% of interviewed customers expressed the highest level of satisfaction with the platform.
Carter Prince, Partner at CVS Health Ventures, emphasized that Fathom is delivering real ROI at a critical time. As the nation’s leading autonomous coding platform, Fathom is now supported by a world-class group of investors, including 8VC, GV, and Lightspeed Venture Partners, to meet the accelerating demand for enterprise AI in the healthcare ecosystem.
